Track topics on Twitter Track topics that are important to you
BOSTON, July 19, 2017 /PRNewswire/ -- Burns & Levinson today announced the launch of a new blog called CannaBusiness Advisory, which will provide insight on a wide range of business topics, f...
BOSTON — Additional povidone-iodine given after placement of a lid speculum can significantly decrease the incidence of post-injection endophthalmitis, according to a speaker at the American Society...
FOSTER CITY, Calif., June 14, 2017 /PRNewswire/ -- MORE Health, Inc. (www.morehealth.com) and Castle Connolly Medical Ltd. (www.castleconnolly.com) announced today that they have formed a strateg...
Bristol-Myers Squibb Announces Availability of New ORENCIA® (abatacept) Subcutaneous Administration Option for Patients 2 Years of Age and Older with Moderately to Severely Active Polyarticular Juvenile Idiopathic Arthritis (JIA)
New prefilled syringe option can be administered at home Bristol-Myers Squibb Company (NYSE:BMY) announced today the availability of a new FDA-approved subcutaneous (SC...
The aim of this trial is to test a novel network approach (Bringmann et al., 2013), which enables to investigate the complex, interdependent network of self-control and its influences in e...
We have published hundreds of Eichen Levinson & Crutchlow, LLP news stories on BioPortfolio along with dozens of Eichen Levinson & Crutchlow, LLP Clinical Trials and PubMed Articles about Eichen Levinson & Crutchlow, LLP for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Eichen Levinson & Crutchlow, LLP Companies in our database. You can also find out about relevant Eichen Levinson & Crutchlow, LLP Drugs and Medications on this site too.